Increased age, high body mass index and low HDL-C levels are related to an echolucent carotid intima-media: The METEOR study

Journal of Internal Medicine

Volumn 272, Issue 3, 2012, Pages 257-266

  Peters, S A E ^a   Lind, L ^b   Palmer, M K ^c   Grobbee, D E ^a   Crouse, J R ^d   O'Leary, D H ^e   Evans, G W ^d   Raichlen, J ^f   Bots, M L ^a   Den Ruijter, H M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c KEELE UNIVERSITY   (United Kingdom)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e Carney Hospital   (United States)

^f ASTRAZENECA   (United Kingdom)

Author keywords

Atherosclerosis; Carotid intima media thickness; Carotid ultrasound; Echolucency; Risk factors

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; ROSUVASTATIN;

ADULT; AGING; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; COMMON CAROTID ARTERY; ECHOCARDIOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POST HOC ANALYSIS; PRIORITY JOURNAL;

AGE FACTORS; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID ARTERY, COMMON; CHOLESTEROL, HDL; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 84865568204     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2011.02505.x     Document Type: Article

References (41)

1. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-43.
2. World Health Organization. The World Health Report. 2008. http://www.who.int/whr/en/. Accessed June 7, 2009.
3. Bots ML, Evans GW, Riley WA, Grobbee DE. Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view. Stroke 2003; 34: 2985-94.
4. Gronholdt ML, Wiebe BM, Laursen H, Nielsen TG, Schroeder TV, Sillesen H. Lipid-rich carotid artery plaques appear echolucent on ultrasound B-mode images and may be associated with intraplaque haemorrhage. Eur J Vasc Endovasc Surg 1997; 14: 439-45.
5. Gronholdt ML. Ultrasound and lipoproteins as predictors of lipid-rich, rupture-prone plaques in the carotid artery. Arterioscler Thromb Vasc Biol 1999; 19: 2-13.
6. Gronholdt ML, Nordestgaard BG, Schroeder TV, Vorstrup S, Sillesen H. Ultrasonic echolucent carotid plaques predict future strokes. Circulation 2001; 104: 68-73.
7. Andersson J, Sundstrom J, Kurland L et al. The carotid artery plaque size and echogenicity are related to different cardiovascular risk factors in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Lipids 2009; 44: 397-403.
8. Polak JF, Shemanski L, O'Leary DH et al. Hypoechoic plaque at US of the carotid artery: an independent risk factor for incident stroke in adults aged 65years or older. Cardiovascular Health Study. Radiology 1998; 208: 649-54.
9. Reiter M, Effenberger I, Sabeti S et al. Increasing carotid plaque echolucency is predictive of cardiovascular events in high-risk patients. Radiology 2008; 248: 1050-5.
10. Honda O, Sugiyama S, Kugiyama K et al. Echolucent carotid plaques predict future coronary events in patients with coronary artery disease. J Am Coll Cardiol 2004; 43: 1177-84.
11. Mathiesen EB, Bonaa KH, Joakimsen O. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the tromso study. Circulation 2001; 103: 2171-5.
12. Lind L, Andersson J, Ronn M, Gustavsson T. The echogenecity of the intima-media complex in the common carotid artery is closely related to the echogenecity in plaques. Atherosclerosis 2007; 195: 411-14.
13. Wohlin M, Sundstrom J, Andren B, Larsson A, Lind L. An echolucent carotid artery intima-media complex is a new and independent predictor of mortality in an elderly male cohort. Atherosclerosis 2009; 205: 486-91.
14. Lind L, Andersson J, Larsson A, Sandhagen B. Shear stress in the common carotid artery is related to both intima-media thickness and echogenecity. The Prospective Investigation of the Vasculature in Uppsala Seniors study. Clin Hemorheol Microcirc 2009; 43: 299-308.
15. Andersson J, Sundstrom J, Gustavsson T et al. Echogenecity of the carotid intima-media complex is related to cardiovascular risk factors, dyslipidemia, oxidative stress and inflammation: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Atherosclerosis 2009; 204: 612-18.
16. Crouse JR III, Grobbee DE, O'Leary DH et al. Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin in subclinical atherosclerosis--the rationale and methodology of the METEOR study. Cardiovasc Drugs Ther 2004; 18: 231-8.
17. Crouse JR III, Raichlen JS, Riley WA et al. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA 2007; 297: 1344-53.
18. Liang Q, Wendelhag I, Wikstrand J, Gustavsson T. A multiscale dynamic programming procedure for boundary detection in ultrasonic artery images. IEEE Trans Med Imaging 2000; 19: 127-42.
19. Goncalves I, Lindholm MW, Pedro LM et al. Elastin and calcium rather than collagen or lipid content are associated with echogenicity of human carotid plaques. Stroke 2004; 35(12): 2795-800.
20. Kardoulas DG, Katsamouris AN, Gallis PT et al. Ultrasonographic and histologic characteristics of symptom-free and symptomatic carotid plaque. Cardiovasc Surg 1996; 4: 580-90.
21. Nordestgaard BG, Gronholdt ML, Sillesen H. Echolucent rupture-prone plaques. Curr Opin Lipidol 2003; 14: 505-12.
22. Gronholdt ML, Nordestgaard BG, Wiebe BM, Wilhjelm JE, Sillesen H. Echo-lucency of computerized ultrasound images of carotid atherosclerotic plaques are associated with increased levels of triglyceride-rich lipoproteins as well as increased plaque lipid content. Circulation 1998; 97: 34-40.
23. Kofoed SC, Gronholdt ML, Bismuth J, Wilhjelm JE, Sillesen H, Nordestgaard BG. Echolucent, rupture-prone carotid plaques associated with elevated triglyceride-rich lipoproteins, particularly in women. J Vasc Surg 2002; 36: 783-92.
24. Mathiesen EB, Bonaa KH, Joakimsen O. Low levels of high-density lipoprotein cholesterol are associated with echolucent carotid artery plaques: the tromso study. Stroke 2001; 32: 1960-5.
25. Schmidt C, Fagerberg B, Wikstrand J, Hulthe J. Multiple risk factor intervention reduces cardiovascular risk in hypertensive patients with echolucent plaques in the carotid artery. J Intern Med 2003; 253: 430-8.
26. Crisby M, Nordin-Fredriksson G, Shah PK, Yano J, Zhu J, Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 2001; 103: 926-33.
27. Makris GC, Lavida A, Nicolaides AN, Geroulakos G. The effect of statins on carotid plaque morphology: a LDL-associated action or one more pleiotropic effect of statins?Atherosclerosis 2010; 213: 8-20.
28. Ostling G, Goncalves I, Wikstrand J, Berglund G, Nilsson J, Hedblad B. Long-term treatment with low-dose metoprolol CR/XL is associated with increased plaque echogenicity: the Beta-blocker Cholesterol-lowering Asymptomatic Plaque Study (BCAPS). Atherosclerosis 2011; 215: 440-5.
29. Johnsen SH, Mathiesen EB, Fosse E et al. Elevated high-density lipoprotein cholesterol levels are protective against plaque progression: a follow-up study of 1952 persons with carotid atherosclerosis the Tromso study. Circulation 2005; 112: 498-504.
30. Gordon DJ, Probstfield JL, Garrison RJ et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989; 79: 8-15.
31. Vergeer M, Holleboom AG, Kastelein JJ, Kuivenhoven JA. The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?J Lipid Res 2010; 51: 2058-73.
32. Briel M, Ferreira-Gonzalez I, You JJ et al. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. BMJ 2009; 338: b92.
33. deGoma EM, deGoma RL, Rader DJ. Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches. J Am Coll Cardiol 2008; 51: 2199-211.
34. Heinecke J. HDL and cardiovascular-disease risk--time for a new approach?N Engl J Med 2011; 364: 170-1.
35. Khera AV, Cuchel M, de la Llera-Moya M et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 2011; 364: 127-35.
36. Tall AR. Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins. J Intern Med 2008; 263: 256-73.
37. de la Llera-Moya M, Drazul-Schrader D, Asztalos BF, Cuchel M, Rader DJ, Rothblat GH. The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages. Arterioscler Thromb Vasc Biol 2010; 30: 796-801.
38. Staub D, Schinkel AF, Coll B et al. Contrast-enhanced ultrasound imaging of the vasa vasorum: from early atherosclerosis to the identification of unstable plaques. JACC Cardiovasc Imaging 2010; 3: 761-71.
39. Coli S, Magnoni M, Sangiorgi G et al. Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity. J Am Coll Cardiol 2008; 52: 223-30.
40. Staub D, Partovi S, Schinkel AF et al. Correlation of carotid artery atherosclerotic lesion echogenicity and severity at standard US with intraplaque neovascularization detected at contrast-enhanced US. Radiology 2011; 258: 618-26.
41. Finn AV, Kolodgie FD, Virmani R. Correlation Between Carotid Intimal/Medial Thickness and Atherosclerosis. A Point of View From Pathology. Arterioscler Thromb Vasc Biol 2010; 30: 177-81.